3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
9
Ovarian Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Stomach Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Bites and Stings
1
Adenocarcinoma
1
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
dostarlimab
×
Clear all
No trials found.